ERNA vs JD · P/E 0.0, rev $582.0K vs P/E 7.6, rev $187.20B
Eterna Therapeutics Inc (ERNA) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the ERNA and JD stock pages for the full models.
Not investment advice.